Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Net Cash Flow: 2019-2021

Historic Net Cash Flow for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to -$9.7 million.

  • Bright Minds Biosciences' Net Cash Flow fell 2415.32% to -$9.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $14.7 million, marking a year-over-year change of. This contributed to the annual value of -$764,327 for FY2024, which is 78.68% up from last year.
  • As of Q3 2021, Bright Minds Biosciences' Net Cash Flow stood at -$9.7 million, which was down 593.19% from $2.0 million recorded in Q2 2021.
  • In the past 5 years, Bright Minds Biosciences' Net Cash Flow ranged from a high of $20.6 million in Q1 2021 and a low of -$9.7 million during Q3 2021.
  • Moreover, its 3-year median value for Net Cash Flow was $1.1 million (2020), whereas its average is $2.5 million.
  • Per our database at Business Quant, Bright Minds Biosciences' Net Cash Flow surged by 594.04% in 2020 and then slumped by 2,415.32% in 2021.
  • Bright Minds Biosciences' Net Cash Flow (Quarterly) stood at $60,603 in 2019, then spiked by 594.04% to $1.9 million in 2020, then slumped by 2,415.32% to -$9.7 million in 2021.
  • Its Net Cash Flow was -$9.7 million in Q3 2021, compared to $2.0 million in Q2 2021 and $20.6 million in Q1 2021.